Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID‐19)

Surapat, Bhitta; Sungkanuparph, Somnuek; Kirdlarp, Suppachok; Lekpittaya, Nantaporn; Chunnguleum, Krittaya

doi:10.1111/jcpt.13293

Cited by 15 publications

(29 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, 62 (93.9%) of 66 patients in the group negative for SARS-CoV-2 by PCR also received antimicrobials, as did 176 (93.6%) of 188 patients in the PCRpositive group. Despite prolongation of the QT interval being a worrisome ADR that has been identified in large studies, it was uncommon in a Thai study 25 and also in our study. It was possibly underdetected due to our small sample and because ECG monitoring is only performed regularly in intensive care units and in patients at high risk for developing QT prolongation.…”

Section: Discussioncontrasting

confidence: 38%

“…Sun et al 23 also recorded most ADRs as disorders of the gastrointestinal tract (23%), followed by liver enzyme changes (13.8%). In a study by Surapat et al 25 in Thailand, diarrhea was also the most common adverse reaction, occurring in 9% of patients who used protease inhibitors (lopinavir/ritonavir and darunavir/ritonavir). Notably, however, 2%-50% of patients diagnosed with COVID-19 reported diarrhea, [26][27][28][29] and this is a limitation of any study that seeks to identify ADRs.…”

Section: Discussionmentioning

confidence: 99%

“…We believe that the capacity of this French center to identify adverse cardiac reactions was extremely systematic and properly structured where it was possible to identify these on a large scale, different from the low numbers identified in our study and in the Thai study. 25 The risk of drug interactions is higher in the elderly population, those with multiple comorbidities, as well as in the critical care environment. 31 Drug-drug interactions result from their pharmacokinetic and pharmacodynamic properties and, in patients with COVID-19, an inflammatory response can alter the pharmacokinetic behavior of drugs.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)

Marins

Marra

Edmond

et al. 2021

ASHE

View full text Add to dashboard Cite

Objectives: To identify drugs that were administered off label to hospitalized patients with suspected coronavirus disease 2019 (COVID-19) and to identify adverse drug reactions (ADRs) and drug–drug interactions associated with these therapies. Methods: This case–control study was conducted in a Brazilian hospital from March to April 2020 among patients with suspected COVID-19, comparing those with positive severe acute respiratory coronavirus virus 2 (SARS-CoV-2) reverse-transcriptase polymerase chain reaction (RT-PCR) results and those with negative results. Results: The most commonly used medications in both groups were azithromycin and hydroxychloroquine. There was a significantly higher prevalence of reactions among patients with positive RT-PCR for SARS-CoV-2 (48.5% vs 28.8%; P = .008) in the propensity score–matched cohort, and the most commonly reported ADRs among these patients were diarrhea (43.8%), elevated liver enzymes (31.3%), and nausea and vomiting (29.7%). Conclusions: Our data demonstrate that ADRs and drug–drug interactions are common with off-label treatments for COVID-19.

show abstract

Section: Discussioncontrasting

confidence: 38%

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)

Marins

Marra

Edmond

et al. 2021

ASHE

View full text Add to dashboard Cite

show abstract

“…12 In another hospital setup in Thailand, clinical pharmacists effectively monitored patients remotely, especially with regard to drug dosing design, through the telemedicine unit. 20 Telepharmacy increases the access of vulnerable patient populations, especially those with COVID-19, to health consultation services; in a prospective observational study conducted across United Arab Emirates, it was found to decrease the rate of medication dispensing errors and prescription-related errors and improve pharmacist counseling of patients. 21 Thus, patients contacted through telepharmacy services were found to be more likely to get tested, maintain home quarantine, and take paracetamol for fever associated with COVID-19.…”

Section: Telepharmacy and Telehealth Consultingmentioning

confidence: 99%

Expanded roles of community pharmacists in COVID-19: A scoping literature review

Pantasri¹

2022

Journal of the American Pharmacists Association

View full text Add to dashboard Cite

Background COVID-19 has affected the world healthcare system adversely, but has also brought out innovative roles for healthcare professionals to cater to growing healthcare needs. Community pharmacists provide community pharmacy services and can play a vital role in fighting the pandemic by taking on novel roles that complement their pre-existing roles. Objectives To provide a scoping review of current and emerging literature about the novel roles adopted by community pharmacists during the COVID-19 pandemic. Methods Online databases such as Google Scholar and PubMed were searched systematically using the keywords “COVID-19”, AND “pharmacist”, AND “community”. Articles were selected based on availability of full text in English language, with time limit from 1 st December 2019 to 31 st October 2021; case reports, cross-sectional studies, literature reviews, qualitative studies and systematic reviews were included while commentary reviews and editorials were excluded from the search methodology. An independent review of the articles was carried out for inclusion based on relatability to study subject; those chosen were screened for references to find additional gray literature. Findings were arranged in themes and the results were organized accordingly. Results Novel roles for community pharmacists were found in relation to maintenance of drug supply chains; delivery of tele-pharmacy and telehealth services; provision of ambulatory pharmacy services; use of digital software to coordinate medication delivery for patients with chronic conditions; dispelling of misinformation; and roles in research and clinical trials. Roles in a post-COVID world regarding immunization of population, and involvement in lifting lockdown strictures alongside other stakeholders were also explored. Conclusion Although COVID-19 has challenged the healthcare system, it has also provided an opportunity for development of novel and innovative roles that can ultimately have profound consequences for the healthcare system. Community pharmacists, despite facing multiple challenges in the community, should be facilitated to adapt with these new roles, which can be beneficial in achieving mass immunization and better healthcare in a post-COVID world.

show abstract

“… Qatar [ 34 ] •A clinical pharmacist’s team dedicated as the frontline responders for the new established COVID-19 hospitals situated across Qatar and provided clinical interventions and partook in daily rounds. Thailand [ 73 ] •Clinical pharmacist team provided tele-monitoring service on daily basis for every patient by using physician order entry system. •Co-operated with physicians and nurses for handling critical cases of COVID-19.…”

Section: Contributions Of Clinical Pharmacists In Covid-19mentioning

confidence: 99%

A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future

et al. 2021

View full text Add to dashboard Cite

Background COVID-19, a respiratory tract infection caused by SARS-CoV-2, is a burning question worldwide as it gives rise to a pandemic situation. No specific medications are still recommended for COVID-19; however, healthcare support is crucial for ameliorating the disease condition. Pharmacists are the frontline fighters who are responsible for providing healthcare support to the COVID-19 infected patients around the world. This review endeavored to briefly rationalize the contributions of several pharmacy professionals in diverse fields along with their collaborative efforts and dedication regarding their limitations during the COVID-19 situation and view the prospects of pharmaceutical care services in the post-pandemic period. Main body of the abstract Online databases were utilized to search for scholarly articles and organizational websites, to sum up the information about the contemporary and expanded role of pharmacists. Key articles were retrieved from Google Scholar, PubMed, and Science Direct databases using terms: “COVID-19,” “novel coronavirus,” “community,” “industrial,” “hospital,” “clinical,” “recognition,” “obstacles,” “collaboration,” “SARS-CoV-2,” “healthcare,” and “outbreak” in combination with “pharmacist.” The articles were included from the inception of the pandemic to January 25, 2021. The current review found pharmacist’s global contributions and involvements with other professionals to provide healthcare services amidst COVID-19. This included testing of suspects, providing medical information, psycho-social support, debunking myths, mitigating drug shortage events, telemedicine, e-prescription, infection control, and controlling the drug supply chain. In many countries, pharmacists’ activities were much appreciated but in some countries, they were not properly acknowledged for their contributions amidst COVID-19 outbreak. They played additional roles such as participating in the antimicrobial stewardship team, improving value-added services, conducting clinical data analysis to suppress the outspread of the SARS-CoV-2. Short conclusion During the COVID-19 pandemic while the whole world is fighting against an invisible virus, the pharmacists are the earnest hero to serve their responsibilities along with additional activities. They need to be prepared and collaborate with other healthcare professionals further to meet the challenges of post-pandemic circumstances.

show abstract

Role of clinical pharmacists in telemonitoring for patients with Coronavirus Disease 2019 (COVID‐19)

Cited by 15 publications

References 23 publications

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)

Adverse drug reactions and drug interactions in the treatment of hospitalized patients with coronavirus disease 2019 (COVID-19)

Expanded roles of community pharmacists in COVID-19: A scoping literature review

A comprehensive review on global contributions and recognition of pharmacy professionals amidst COVID-19 pandemic: moving from present to future

Contact Info

Product

Resources

About